CD86 functions as a co-inhibitory receptor to drive CD8⁺ T-cell exhaustion and is associated with poor immune recovery in chronic HIV-1 infection
Аннотация
Background Chronic HIV-1 infection is characterized by persistent CD8⁺ T-cell exhaustion, which impedes effective viral control and serves as a major barrier to achieving complete immune reconstitution in people living with HIV (PLWH) receiving suppressive antiretroviral therapy (ART). While classic co-inhibitory receptors are central to this process, the functional plasticity of canonical co-stimulatory molecules in driving T-cell exhaustion remains underexplored. Here, we investigated the role of T cell-intrinsic CD86, a member of the B7 family traditionally recognized as a co-stimulatory ligand on antigen-presenting cells (APCs), in T-cell exhaustion during HIV-1 infection. Methods Flow cytometry was performed to assess CD86 expression on CD8⁺ T cells and to characterize their phenotypic, functional, and intracellular signaling profiles. HIV-1-specific responses were evaluated following peptide pool stimulation, and cytokine stimulation assays in vitro were used to identify factors promoting CD86 upregulation. Bulk RNA sequencing (RNA-seq), qRT-PCR, and analysis of publicly available single-cell RNA-seq (scRNA-seq) datasets were employed to characterize transcriptional features and provide external validation. Results We identified a significantly elevated frequency of CD86⁺CD8⁺ T cells in treatment-naive PLWH, which strongly correlated with HIV-1 disease progression and persistent immune activation. Phenotypic and functional analyses, supplemented by scRNA-seq, revealed that these cells exhibited a profound exhaustion program, characterized by upregulation of co-inhibitory receptors, impaired effector function, and distinct transcriptional reprogramming. We identified IL-15 as a key driver of intrinsic CD86 upregulation, linking excessive proliferation-driven replicative stress with functional impairment during HIV-1 infection. Mechanistically, we demonstrated that T cell-intrinsic CD86 functioned as a non-canonical co-inhibitory receptor that drove exhaustion via reverse signaling, which suppressed the Akt-mTOR and NF-κB (p50) signaling pathways. Furthermore, high baseline frequencies of CD86⁺CD8⁺ T cells showed potential predictive value for poor immune recovery after ART. Conclusions Our findings established CD86 as a novel regulator of CD8⁺ T-cell exhaustion and highlighted its potential as a biomarker for predicting immune reconstitution in PLWH. These insights offer a new perspective on the functional plasticity of co-inhibitory molecules and identify CD86 as a potential target for therapeutic intervention.